Hypoxia induces resistance to ALK inhibitors in the H3122 non-small cell lung cancer cell line with an ALK rearrangement via epithelial-mesenchymal transition

Akihiro Kogita, Yosuke Togashi, Hidetoshi Hayashi, Shunsuke Sogabe, Masato Terashima, Marco A. De Velasco, Kazuko Sakai, Yoshihiko Fujita, Shuta Tomida, Yoshifumi Takeyama, Kiyotaka Okuno, Kazuhiko Nakagawa, Kazuto Nishio

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Patients with non-small cell lung cancer (NSCLC) with echinoderm microtubule-associated protein-like 4 (EML4)-anaplastic lymphoma kinase (ALK) rearrangements generally respond to ALK inhibitors such as crizotinib. However, some patients with EML4-ALK rearrangements respond poorly to crizotinib. Hypoxia is involved in the resistance to chemotherapeutic treatments in several cancers, and we investigated the association between the responses to ALK inhibitors and hypoxia. Sensitivity of the H3122 NSCLC cell line (EML4-ALK rearrangement) to ALK inhibitors (crizotinib or alectinib) was investigated during a normoxic or hypoxic state using an MTT assay. We found that the cell line was resistant to the inhibitors during hypoxia. Hypoxia mediated morphologic changes, including cell scattering and the elongation of the cell shape, that are characteristic of the epithelial-mesenchymal transition (EMT). A migration assay demonstrated that the number of migrating cells increased significantly during hypoxia, compared with during normoxia. Regarding EMT-related molecules, the expressions of slug, vimentin, and fibronectin were increased while that of E-cadherin was decreased by hypoxia. In addition, hypoxia inducible factor 1A-knockdown cancelled the hypoxia-induced EMT and resistance. Our findings indicate that hypoxia induces resistance to ALK inhibitors in NSCLC with an EML4-ALK rearrangement via the EMT.

Original languageEnglish
Pages (from-to)1430-1436
Number of pages7
JournalInternational Journal of Oncology
Volume45
Issue number4
DOIs
Publication statusPublished - 2014
Externally publishedYes

Fingerprint

Epithelial-Mesenchymal Transition
Non-Small Cell Lung Carcinoma
Cell Line
anaplastic lymphoma kinase
Hypoxia
Gastropoda
Cell Shape
Vimentin
Cadherins
Fibronectins
Cell Count
MAP4

Keywords

  • ALK inhibitor
  • EML4-ALK rearrangement
  • Epithelial-mesenchymal transition
  • Hypoxia
  • Non-small cell lung cancer

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Medicine(all)

Cite this

Hypoxia induces resistance to ALK inhibitors in the H3122 non-small cell lung cancer cell line with an ALK rearrangement via epithelial-mesenchymal transition. / Kogita, Akihiro; Togashi, Yosuke; Hayashi, Hidetoshi; Sogabe, Shunsuke; Terashima, Masato; De Velasco, Marco A.; Sakai, Kazuko; Fujita, Yoshihiko; Tomida, Shuta; Takeyama, Yoshifumi; Okuno, Kiyotaka; Nakagawa, Kazuhiko; Nishio, Kazuto.

In: International Journal of Oncology, Vol. 45, No. 4, 2014, p. 1430-1436.

Research output: Contribution to journalArticle

Kogita, A, Togashi, Y, Hayashi, H, Sogabe, S, Terashima, M, De Velasco, MA, Sakai, K, Fujita, Y, Tomida, S, Takeyama, Y, Okuno, K, Nakagawa, K & Nishio, K 2014, 'Hypoxia induces resistance to ALK inhibitors in the H3122 non-small cell lung cancer cell line with an ALK rearrangement via epithelial-mesenchymal transition', International Journal of Oncology, vol. 45, no. 4, pp. 1430-1436. https://doi.org/10.3892/ijo.2014.2574
Kogita, Akihiro ; Togashi, Yosuke ; Hayashi, Hidetoshi ; Sogabe, Shunsuke ; Terashima, Masato ; De Velasco, Marco A. ; Sakai, Kazuko ; Fujita, Yoshihiko ; Tomida, Shuta ; Takeyama, Yoshifumi ; Okuno, Kiyotaka ; Nakagawa, Kazuhiko ; Nishio, Kazuto. / Hypoxia induces resistance to ALK inhibitors in the H3122 non-small cell lung cancer cell line with an ALK rearrangement via epithelial-mesenchymal transition. In: International Journal of Oncology. 2014 ; Vol. 45, No. 4. pp. 1430-1436.
@article{268469a9796e4cb6894308e0588edea4,
title = "Hypoxia induces resistance to ALK inhibitors in the H3122 non-small cell lung cancer cell line with an ALK rearrangement via epithelial-mesenchymal transition",
abstract = "Patients with non-small cell lung cancer (NSCLC) with echinoderm microtubule-associated protein-like 4 (EML4)-anaplastic lymphoma kinase (ALK) rearrangements generally respond to ALK inhibitors such as crizotinib. However, some patients with EML4-ALK rearrangements respond poorly to crizotinib. Hypoxia is involved in the resistance to chemotherapeutic treatments in several cancers, and we investigated the association between the responses to ALK inhibitors and hypoxia. Sensitivity of the H3122 NSCLC cell line (EML4-ALK rearrangement) to ALK inhibitors (crizotinib or alectinib) was investigated during a normoxic or hypoxic state using an MTT assay. We found that the cell line was resistant to the inhibitors during hypoxia. Hypoxia mediated morphologic changes, including cell scattering and the elongation of the cell shape, that are characteristic of the epithelial-mesenchymal transition (EMT). A migration assay demonstrated that the number of migrating cells increased significantly during hypoxia, compared with during normoxia. Regarding EMT-related molecules, the expressions of slug, vimentin, and fibronectin were increased while that of E-cadherin was decreased by hypoxia. In addition, hypoxia inducible factor 1A-knockdown cancelled the hypoxia-induced EMT and resistance. Our findings indicate that hypoxia induces resistance to ALK inhibitors in NSCLC with an EML4-ALK rearrangement via the EMT.",
keywords = "ALK inhibitor, EML4-ALK rearrangement, Epithelial-mesenchymal transition, Hypoxia, Non-small cell lung cancer",
author = "Akihiro Kogita and Yosuke Togashi and Hidetoshi Hayashi and Shunsuke Sogabe and Masato Terashima and {De Velasco}, {Marco A.} and Kazuko Sakai and Yoshihiko Fujita and Shuta Tomida and Yoshifumi Takeyama and Kiyotaka Okuno and Kazuhiko Nakagawa and Kazuto Nishio",
year = "2014",
doi = "10.3892/ijo.2014.2574",
language = "English",
volume = "45",
pages = "1430--1436",
journal = "International Journal of Oncology",
issn = "1019-6439",
publisher = "Spandidos Publications",
number = "4",

}

TY - JOUR

T1 - Hypoxia induces resistance to ALK inhibitors in the H3122 non-small cell lung cancer cell line with an ALK rearrangement via epithelial-mesenchymal transition

AU - Kogita, Akihiro

AU - Togashi, Yosuke

AU - Hayashi, Hidetoshi

AU - Sogabe, Shunsuke

AU - Terashima, Masato

AU - De Velasco, Marco A.

AU - Sakai, Kazuko

AU - Fujita, Yoshihiko

AU - Tomida, Shuta

AU - Takeyama, Yoshifumi

AU - Okuno, Kiyotaka

AU - Nakagawa, Kazuhiko

AU - Nishio, Kazuto

PY - 2014

Y1 - 2014

N2 - Patients with non-small cell lung cancer (NSCLC) with echinoderm microtubule-associated protein-like 4 (EML4)-anaplastic lymphoma kinase (ALK) rearrangements generally respond to ALK inhibitors such as crizotinib. However, some patients with EML4-ALK rearrangements respond poorly to crizotinib. Hypoxia is involved in the resistance to chemotherapeutic treatments in several cancers, and we investigated the association between the responses to ALK inhibitors and hypoxia. Sensitivity of the H3122 NSCLC cell line (EML4-ALK rearrangement) to ALK inhibitors (crizotinib or alectinib) was investigated during a normoxic or hypoxic state using an MTT assay. We found that the cell line was resistant to the inhibitors during hypoxia. Hypoxia mediated morphologic changes, including cell scattering and the elongation of the cell shape, that are characteristic of the epithelial-mesenchymal transition (EMT). A migration assay demonstrated that the number of migrating cells increased significantly during hypoxia, compared with during normoxia. Regarding EMT-related molecules, the expressions of slug, vimentin, and fibronectin were increased while that of E-cadherin was decreased by hypoxia. In addition, hypoxia inducible factor 1A-knockdown cancelled the hypoxia-induced EMT and resistance. Our findings indicate that hypoxia induces resistance to ALK inhibitors in NSCLC with an EML4-ALK rearrangement via the EMT.

AB - Patients with non-small cell lung cancer (NSCLC) with echinoderm microtubule-associated protein-like 4 (EML4)-anaplastic lymphoma kinase (ALK) rearrangements generally respond to ALK inhibitors such as crizotinib. However, some patients with EML4-ALK rearrangements respond poorly to crizotinib. Hypoxia is involved in the resistance to chemotherapeutic treatments in several cancers, and we investigated the association between the responses to ALK inhibitors and hypoxia. Sensitivity of the H3122 NSCLC cell line (EML4-ALK rearrangement) to ALK inhibitors (crizotinib or alectinib) was investigated during a normoxic or hypoxic state using an MTT assay. We found that the cell line was resistant to the inhibitors during hypoxia. Hypoxia mediated morphologic changes, including cell scattering and the elongation of the cell shape, that are characteristic of the epithelial-mesenchymal transition (EMT). A migration assay demonstrated that the number of migrating cells increased significantly during hypoxia, compared with during normoxia. Regarding EMT-related molecules, the expressions of slug, vimentin, and fibronectin were increased while that of E-cadherin was decreased by hypoxia. In addition, hypoxia inducible factor 1A-knockdown cancelled the hypoxia-induced EMT and resistance. Our findings indicate that hypoxia induces resistance to ALK inhibitors in NSCLC with an EML4-ALK rearrangement via the EMT.

KW - ALK inhibitor

KW - EML4-ALK rearrangement

KW - Epithelial-mesenchymal transition

KW - Hypoxia

KW - Non-small cell lung cancer

UR - http://www.scopus.com/inward/record.url?scp=84907462932&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907462932&partnerID=8YFLogxK

U2 - 10.3892/ijo.2014.2574

DO - 10.3892/ijo.2014.2574

M3 - Article

C2 - 25096400

AN - SCOPUS:84907462932

VL - 45

SP - 1430

EP - 1436

JO - International Journal of Oncology

JF - International Journal of Oncology

SN - 1019-6439

IS - 4

ER -